The global tissue banking market was valued at USD 2.21 Billion in 2025, driven by the rapid advancements in technologies supporting ex vivo cord blood expansion across the globe. The market is anticipated to grow at a CAGR of 10.60% during the forecast period of 2026-2035 to achieve a value of USD 6.05 Billion by 2035.
Base Year
Historical Period
Forecast Period
Growing demand for regenerative medicine and transplantation therapies is accelerating the adoption of advanced tissue preservation and storage solutions, propelling market growth.
Increasing public awareness and government support for organ and tissue donation programmes are expected to significantly enhance tissue bank capacities and infrastructure in the coming years.
Technological advancements in cryopreservation, sterilisation, and biobanking software are streamlining tissue handling processes, improving quality, and fostering long-term market development across healthcare and research sectors.
Compound Annual Growth Rate
10.6%
Value in USD Billion
2026-2035
*this image is indicative*
Tissue banking is the process of collecting, processing, storing, and distributing human tissues for clinical use, research, and education. These tissues, which may include skin, bone, corneas, heart valves, and tendons, are preserved through specialised techniques such as cryopreservation and sterilisation to maintain viability and safety. Tissue banks ensure the quality and traceability of samples, supporting various medical treatments including reconstructive surgeries, transplants, and regenerative therapies. By providing ethically sourced and regulated tissues, tissue banking plays a crucial role in advancing modern medicine and improving patient outcomes worldwide.
Development of Private Biobanks to Advance Market Value
Rising emphasis on women-specific health research and increased funding for private tissue banks are key drivers of tissue banking market growth. For instance, in January 2025, BioGrad launched Europe’s first private women’s health research tissue bank, a 10,000 sq ft facility in Liverpool, following an EUR 25 million (USD 31.5 million) investment in women's health. The facility stores menstrual blood, peripheral blood, and umbilical cord tissues, targeting conditions like PCOS, endometriosis, and cancer. With partnerships including Liverpool Women’s Hospital and sample donor incentives, the initiative will significantly expand the scope and diversity of biobanking. Over the forecast period, this development is expected to improve sample availability, drive research innovation, and diversify tissue types in global repositories.
Rising Focus on Developing Targeted Therapies to Boost Tissue Banking Market Demand
Increasing demand for targeted therapies and investment in chronic disease research are key contributors to tissue banking market expansion. For instance, in October 2024, the Orland Bethel Family Foundation invested USD 18.5 million to develop a biological specimen repository at the Orland Bethel Family Musculoskeletal Research Center at the University of Pittsburgh. The repository aims to support research into arthritis and other musculoskeletal diseases, which affect millions globally. This initiative is expected to enhance specimen accessibility and long-term data generation for high-burden conditions. Over the forecast period, the project will likely accelerate musculoskeletal therapeutic discoveries and strengthen the research infrastructure, thus positively impacting the market.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Tissue Banking Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Tissue Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Media and Consumables to Dominate the Segmentation by Product
Media and consumables are anticipated to dominate the market by product due to their indispensable role in tissue preservation, processing, and storage. Unlike capital-intensive equipment, consumables such as storage vials, reagents, and cryoprotectants are required continuously across all procedures. Their recurrent usage in various workflows, including thawing, cryopreservation, and quality control, ensures a consistent revenue stream. As tissue banking expands into regenerative medicine, oncology, and personalised therapies, the demand for reliable consumables will further rise. Innovations in preservation solutions and increased biobanking activities globally are also set to bolster this segment’s growth during the forecast period.
Bone Tissues to Hold a Significant Tissue Banking Market Value for Segmentation by Tissue Type
Bone tissue is poised to lead the market by tissue type due to its wide-ranging applications in orthopaedic surgeries, trauma repair, and dental implants. The rising incidence of musculoskeletal disorders and sports injuries has driven demand for bone grafts and substitutes. Bone’s high transplantation success rate and ability to integrate with host tissues also contribute to its preference. Additionally, advancements in 3D printing and allograft processing technologies are supporting efficient bone tissue utilisation. These factors collectively position the bone segment as a dominant contributor to market value in the forecast years.
Therapeutic Applications to Lead the Segment by Application
Therapeutic applications are expected to capture the largest market share. The growing burden of chronic diseases, the increasing number of surgical procedures, and heightened demand for tissue transplants in areas such as cardiology, neurology, and orthopaedics are key drivers. Furthermore, the adoption of regenerative therapies, including stem cell-based treatments and skin grafts, underlines the therapeutic significance of stored tissues. Rising government and private investments in healthcare infrastructure are further promoting access to transplantation procedures. This segment's role in improving clinical outcomes makes it central to the market’s ongoing expansion.
Biobanks to Dominate the Tissue Banking Market Segmentation by End User
Biobanks are set to dominate the market by end user due to their specialised infrastructure and central role in large-scale tissue collection and preservation. These institutions are essential for supporting scientific research, drug development, and personalised medicine. Increasing collaborations between biobanks, academic institutions, and pharmaceutical companies are accelerating innovation and expanding sample diversity. Moreover, global health initiatives focusing on genomics and disease profiling are further boosting biobank activities. As regulatory frameworks evolve to support ethical biobanking, their capacity and operational scale are expected to grow, reinforcing their leadership in the market throughout the forecast period.
North America is expected to hold the largest market share, driven by robust government support for biobanking, an advanced healthcare system, and an extensive network of research institutions. The U.S. boasts one of the highest numbers of registered tissue banks, alongside rising demand for regenerative and transplant-based therapies. Moreover, favourable regulatory frameworks and large-scale investments in personalised medicine are further expanding regional capabilities. Europe follows closely, supported by national biobank initiatives and strong academic collaborations. The Asia-Pacific region is gaining momentum, fuelled by rapid healthcare infrastructure development and growing stem cell research. Meanwhile, Latin America and the Middle East and Africa are witnessing gradual growth through public–private healthcare partnerships and medical tourism.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Seoul, South Korea, Rokit Healthcare Inc. was established in 2012 and is a leader in regenerative medicine and 3D bioprinting technologies. The company’s innovations include the Dr. INVIVO bioprinting platform, which supports personalised tissue engineering and biobank development. Rokit’s portfolio in the tissue banking market focuses on preserving and fabricating human tissues for wound care, skin regeneration, and medical research. Through advanced bioprinting and cell preservation solutions, the company is actively contributing to the advancement of personalised and regenerative therapies globally.
Founded in 1987 and headquartered in Abingdon, Oxfordshire, UK, AMS Biotechnology (AMSBIO) provides high-quality products and services for life sciences research. In the tissue banking sector, AMSBIO offers an extensive range of cryopreservation media, biorepository reagents, and human tissue samples for use in drug development and disease modelling. The company supports biobanks and research institutes with tools for tissue storage, stability, and viability. With a strong presence across Europe and North America, AMSBIO is advancing tissue research through reliable, scalable, and ethically sourced biobanking solutions.
Avantor, Inc., headquartered in Radnor, Pennsylvania, USA, traces its origins back to 1904, with VWR International being a significant subsidiary. The company supplies critical materials and consumables for biopharmaceutical and research applications. In tissue banking, Avantor offers cryogenic storage equipment, cryopreservation reagents, and laboratory-grade consumables used for safe tissue handling, transport, and preservation. Avantor’s global infrastructure supports tissue banks and clinical labs by ensuring quality-controlled environments and end-to-end biorepository support, playing a key role in accelerating therapeutic research and regenerative medicine initiatives.
Established in 1870 and headquartered in Göttingen, Germany, Sartorius AG is a global leader in laboratory and bioprocessing technologies. In the tissue banking domain, Sartorius provides state-of-the-art cell culture solutions, filtration systems, cryopreservation tools, and data monitoring software. Their products ensure optimal conditions for tissue storage and quality control. Sartorius supports tissue banks, research labs, and clinical manufacturers in maintaining regulatory compliance and ensuring tissue integrity. With a strong focus on digitalisation and innovation, Sartorius is enabling reliable tissue preservation for therapeutic, diagnostic, and research purposes.
Azenta Life Sciences, headquartered in Burlington, Massachusetts, USA, emerged from the rebranding of Brooks Life Sciences in 2021. It specialises in sample management, genomic services, and automation solutions for biobanking and life sciences. Azenta provides secure, high-capacity storage solutions, temperature-controlled logistics, and comprehensive tissue sample tracking systems. With global biorepository facilities and cutting-edge cryogenic storage technologies, Azenta serves pharmaceutical companies, hospitals, and research institutions. Its focus on data integrity, regulatory compliance, and sustainability positions it as a vital partner in the global tissue banking ecosystem.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Bio-Rad Laboratories Inc., Eppendorf AG, Thermo Fisher Scientific Inc., LifeLink Tissue Bank, and BioLife Solutions.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Tissue Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share